<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="32738">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02680470</url>
  </required_header>
  <id_info>
    <org_study_id>15/WS/0004</org_study_id>
    <nct_id>NCT02680470</nct_id>
  </id_info>
  <brief_title>Virtual Observed Therapy for Patients With Tuberculosis</brief_title>
  <official_title>Virtual Observed Therapy for Patients With Tuberculosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NHS Lothian</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using modern technology, investigators will observe participants taking their TB tablets
      three times per week using a mobile phone, iPod or computer with camera facilities in the
      participants home environment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Using modern technology, the investigators will observe participants taking their TB tablets
      three times per week using a mobile phone, iPod or computer with camera facilities in the
      participants home environment.

      Investigators will connect to the participants mobile phone, iPod or computer at a mutually
      convenient time three times per week who will observe participants taking their TB
      medication.

      The Virtual Observed Therapy will be carried out using NHS Lothian approved software (mobile
      app called POLYCOM) three times per week. This is software similar to Skype but POLYCOM is
      the approved software we use in NHS Lothian.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment completion rates using VOT compared with historical completion rates.</measure>
    <time_frame>length of TB treatment (usually 6-12 months)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>% Cure from TB treatment</measure>
    <time_frame>length of TB treatment (usually 6-12 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of VOT actually observed divided by the expected VOT observed</measure>
    <time_frame>length of TB treatment (usually 6-12 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction questionnaire at end of treatment</measure>
    <time_frame>length of TB treatment (usually 6-12 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>length of TB treatment (usually 6-12 months)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Tuberculosis</condition>
  <arm_group>
    <arm_group_label>Virtual Observed Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention = Virtual observed therapy of participants taking TB therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Virtual observed therapy</intervention_name>
    <description>Virtual Observation of participants taking their medication</description>
    <arm_group_label>Virtual Observed Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Any patient requiring Tuberculosis treatment

        Exclusion Criteria:

        Those refusing consent; the healthcare professional deems the patient that will not be
        able to comply with VOT
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Karen Haggart</last_name>
    <phone>+44 131 242 3328</phone>
    <email>karen.haggart@nhslothian.scot.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gavin Robertson</last_name>
    <email>Gavin.Robertson@nhslothian.scot.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karen Haggart</last_name>
      <phone>+44 131 242 3328</phone>
      <email>karen.haggart@nhslothian.scot.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Adam T Hill, MBChB MRCP MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 3, 2016</lastchanged_date>
  <firstreceived_date>January 28, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Tuberculosis</keyword>
  <keyword>Management</keyword>
  <keyword>Observed therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tuberculosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
